跳至主要内容
临床试验/CTIS2023-504307-88-00
CTIS2023-504307-88-00进行中(未招募)1 期

Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) in At-risk Pregnancies - 80202135FNAIT3001

Janssen - Cilag International0 个研究点目标入组 38 人开始时间: 2023年9月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Female, =18 years of age at the time of informed consent, Pregnant and an estimated GA (based on ultrasound dating) between Week 13 to 16 at randomization, Has a history of =1 prior pregnancy with FNAIT (including neonatal platelet count <150×109/L), with none of them affected by fetal/neonatal ICH or severe hemorrhage based on medical records, Current pregnancy with presence of maternal anti-HPA-1a alloantibody and positive fetal HPA-1a genotype as confirmed by cell-free fetal DNA in maternal blood, Health status considered stable by the investigator on the basis of physical examination, medical history, vital signs, 12-lead ECG, and clinical laboratory tests performed at screening

排除标准

  • Currently pregnant with multiple gestations (twins or more), History of severe preeclampsia in a previous pregnancy, History of severe FGR (EFW <3rd percentile) in a previous pregnancy, History of myocardial infarction, unstable ischemic heart disease, or stroke, Known allergies, hypersensitivity, or intolerance to nipocalimab or its excipients (refer to the IB)

研究者

相似试验

进行中(未招募)
1 期
First-in-human Study of MH002 in Subjects with Mild to Moderate Ulcerative Colitislcerative ColitisMedDRA version: 20.0Level: PTClassification code 10009900Term: Colitis ulcerativeSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2020-004355-33-CZMRM Health NV45
进行中(未招募)
1 期
First-in-human Study of MH002 in Subjects with Mild to Moderate Ulcerative Colitislcerative ColitisMedDRA version: 20.0Level: PTClassification code 10009900Term: Colitis ulcerativeSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2020-004355-33-BEMRM Health NV45
进行中(未招募)
1 期
First-in-human Study of MH002 in Subjects with Mild to Moderate Ulcerative Colitislcerative ColitisMedDRA version: 20.0Level: PTClassification code 10009900Term: Colitis ulcerativeSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2020-004355-33-PLMRM Health NV45
进行中(未招募)
1 期
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer TreatmentAttention impairment after cancer treatment
EUCTR2007-005435-28-GBEisai Limited71
进行中(未招募)
不适用
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer TreatmentAttention impairment after cancer treatment
EUCTR2007-005442-20-BEEisai Limited70